-
-
-
-
-
-
-
Repligen (RGEN) Tops Q1 EPS by 10c ; Offers Guidance
-
-
-
-
-
-
-
Repligen (RGEN) PT Raised to $200 at UBS on Bioprocessing Recovery
-
-
-
-
-
-
-
Repligen (RGEN) Tops Q3 EPS by 4c ; Offers Guidance
-
-
-
-
-
-
-
Repligen (RGEN) PT Lowered to $135 at Jefferies
-
-
-
-
-
-
-
Repligen (RGEN) Trading LOD, Down 3.6pct
-
-
-
-
-
-
-
Repligen (RGEN) Purchases Bioprocessing Analytics Portfolio from 908 Devices (MASS)
-
-
-
-
-
-
-
Repligen (RGEN) Tops Q4 EPS by 3c ; Offers Guidance
-
433,764 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

